Growth hormone for adults with short bowel syndrome
Part of Digestive system clinical trials.
This trial tests whether a growth hormone injection (Saizeng®) can help adults with short bowel syndrome. The goal is to see if it improves how your body absorbs nutrients and fluids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with short bowel syndrome.
- Your liver and kidney function tests must be within certain limits.
- You agree to use contraception if you or your partner can become pregnant.
- You are willing to follow the study schedule and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.
This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.
This study tests whether a daily injection of human growth hormone (called Sinotropin AQ) can safely help children with unexplained short stature grow taller. It is for children who are shorter than expected but do not have a known medical reason for their short height.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
This trial tests a new medication called glepaglutide to see if it can help people with short bowel syndrome (SBS) who need IV nutrition or fluids at least 3 days a week. The goal is to reduce or even stop the need for these IV treatments.
This study tests different doses of a long-acting growth hormone medicine to see which works best for children who are shorter than expected for their age. It may help improve growth in both early and later stages of puberty.
Hear when a new Short Bowel Syndrome (SBS) in Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.